PURETHAL Grasses Rush Study

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Allergic RhinitisAllergic Rhinoconjunctivitis
Interventions
DRUG

PURETHAL Grasses, 20.000 AUM/ml

subcutaneous injections of increasing doses according to the described regimen

Trial Locations (11)

15831

Practice Scholz, Mahlow

32052

Practice Wrede, Herford

41069

St. Kamillus Krankenhaus Abt. Lungen- und Bronchialheilkunde und Allergologie, Mönchengladbach

44263

Practice Blum, Dortmund

47051

Practice Thieme, Duisburg

53127

Universitätsklinikum Bonn Klinik u. Poliklinik f. Dermatologie, Bonn

56072

Dr. med. Jörg Michael Nebel, Koblenz

60596

Medaimun GmbH, Frankfurt

70499

Practice Termeer, Stuttgart

01307

Uni-Klinikum Carl Gustav Carus Klinik und Poliklinik für HNO, Dresden

D - 65183

Zentrum für Rhinologie & Allergologie, Wiesbaden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

HAL Allergy

INDUSTRY

NCT01059266 - PURETHAL Grasses Rush Study | Biotech Hunter | Biotech Hunter